GRB7 protein over-expression and clinical outcome in breast cancer

Breast Cancer Research and Treatment
Betsy RamseyShiuh-Wen Luoh

Abstract

The growth factor receptor-bound protein-7 gene (GRB7) encodes a multi-domain signal transduction molecule. The purpose of this study was to examine the clinical significance of GRB7 protein expression in human breast cancer. Western blotting analysis of protein extracts from 563 annotated frozen breast tumors was performed. Expression status of GRB7 and HER-2 was correlated with clinical covariates and outcomes. Cox proportional hazards were used to identify factors associated with breast cancer-free interval. The median follow-up was 71 months. P values <0.05 were considered statistically significant (two-sided). A discrepancy between HER-2 and GRB7 protein over-expression was observed. GRB7 protein over-expression was associated with negative estrogen and progesterone receptor status, higher tumor grade, larger primary tumor size, (more) axillary lymph node involvement, higher clinical stage, and shortened breast cancer-free interval. HER-2 protein over-expression was associated only with higher tumor grade. Multi-variate analysis revealed that GRB7 protein over-expression was an independent adverse prognostic factor for breast cancer-free interval (hazard ratio 1.69, 95% confidence interval 1.07-2.67; P = 0.024). The same w...Continue Reading

References

Jun 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·O P KallioniemiJ W Gray
Aug 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A K TandonW L McGuire
Aug 30, 2000·Nature·C M PerouD Botstein
Oct 31, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G PaulettiD J Slamon
Feb 10, 2004·Frontiers in Bioscience : a Journal and Virtual Library·Tang-Long Shen, Jun-Lin Guan
May 4, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Francisco J EstevaGabriel N Hortobagyi
Jan 24, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rosana SáezGail M Clinton
Apr 8, 2006·Endocrine-related Cancer·P Kauraniemi, A Kallioniemi
Dec 29, 2006·The New England Journal of Medicine·Charles E GeyerDavid Cameron
May 22, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Clifford A HudisJo Anne Zujewski
Oct 6, 2007·Carcinogenesis·Tao Bai, Shiuh-Wen Luoh
Oct 24, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lyndsay HarrisUNKNOWN American Society of Clinical Oncology
Sep 24, 2008·The Journal of Pathology·C MarchiòJ S Reis-Filho
Nov 13, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephen ChiaKaren Gelmon
Dec 17, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ton van AgthovenLambert C J Dorssers
Feb 11, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Guido SauterMichael F Press
Jan 1, 2007·Archives of Pathology & Laboratory Medicine·Antonio C WolffUNKNOWN American Society of Clinical Oncology/College of American Pathologists
Sep 1, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·Y NadlerY Kluger
Feb 6, 2010·Proceedings of the National Academy of Sciences of the United States of America·Nien-Pei TsaiLi-Na Wei

❮ Previous
Next ❯

Citations

Oct 19, 2011·Breast Cancer Research and Treatment·Orsi GiriczParaic A Kenny
Sep 22, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Joseph A SparanoRobert Gray
Jan 28, 2014·Breast Cancer Research and Treatment·Reece C C LimJacqueline A Wilce
May 1, 2013·Biochimica Et Biophysica Acta·William JacotPierre-Jean Lamy
Sep 4, 2014·Medical Oncology·Amal Said DarweeshSamar Kamal Kassim
Sep 12, 2015·Journal of Medicinal Chemistry·Gabrielle M WatsonJacqueline A Wilce
Sep 25, 2015·Breast Cancer Research and Treatment·Adela Madrid-ParedesMiguel Ángel Calleja-Hernández
Oct 15, 2013·Cell Reports·Sathish Kumar MungamuriStuart A Aaronson
Jun 4, 2016·Scientific Reports·Menachem J GunzburgJacqueline A Wilce
Mar 19, 2014·Acta Crystallographica. Section F, Structural Biology Communications·Nigus D AmbayeJacqueline A Wilce
Nov 16, 2017·BMC Bioinformatics·Liying YangJianhua Wei
Mar 6, 2016·Applied Immunohistochemistry & Molecular Morphology : AIMM·William W BivinUma Krishnamurti
Dec 24, 2018·Chemical Communications : Chem Comm·Montserrat TerrazasModesto Orozco
Oct 12, 2017·Frontiers in Molecular Biosciences·Gabrielle M WatsonJacqueline A Wilce
Oct 20, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jianrong SangJacqueline A Wilce
May 4, 2020·Archives of Biochemistry and Biophysics·Irene García-PalmeroAntonio Villalobo
Oct 31, 2017·Journal of Medicinal Chemistry·Gabrielle M WatsonJacqueline A Wilce

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.